Author/Authors :
lin, zuyuan zhejiang university - school of medicine, first affiliated hospital - department of hepatobiliary and pancreatic surgery, Hangzhou, China , lin, zuyuan national clinical research center for infectious diseases, Hangzhou, China , xiang, xiaonan national clinical research center for infectious diseases, Hangzhou, China , xiang, xiaonan zhejiang university - school of medicine, first affiliated hospital - department of hepatobiliary and pancreatic surgery, Hangzhou, China , lu, di national clinical research center for infectious diseases, Hangzhou, China , lu, di zhejiang university - school of medicine, first affiliated hospital - department of hepatobiliary and pancreatic surgery, Hangzhou, China , xu, xiao national clinical research center for infectious diseases, Hangzhou, China , xu, xiao zhejiang university - school of medicine, first affiliated hospital - department of hepatobiliary and pancreatic surgery, Hangzhou, China
Abstract :
Editorial: Liver cancer was ranked the sixth most commonly diagnosed cancer with the fourth leading cause of cancer-related deaths worldwide in 2018 (1). Notably, hepatocellular carcinoma (HCC) constitutes 75–85% among all the liver cancer cases, and ranks first morbidity and mortality of malignancies in Chinese males under 60.
